These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14614997)

  • 1. The development and validation of a comorbidity index for prostate cancer among Black men.
    Fleming ST; Pearce KA; McDavid K; Pavlov D
    J Clin Epidemiol; 2003 Nov; 56(11):1064-75. PubMed ID: 14614997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer.
    Riviere P; Tokeshi C; Hou J; Nalawade V; Sarkar R; Paravati AJ; Schiaffino M; Rose B; Xu R; Murphy JD
    JCO Clin Cancer Inform; 2019 Mar; 3():1-7. PubMed ID: 30830794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
    Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
    Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining racial differences in prostate cancer mortality.
    Taksler GB; Keating NL; Cutler DM
    Cancer; 2012 Sep; 118(17):4280-9. PubMed ID: 22246942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data.
    Xiao H; Tan F; Goovaerts P; Ali A; Adunlin G; Huang Y; Gwede C
    J Registry Manag; 2013; 40(4):159-64. PubMed ID: 24625768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
    Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
    Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the effects of comorbidity on breast cancer-specific survival.
    Santorelli ML; Hirshfield KM; Steinberg MB; Lin Y; Rhoads GG; Bandera EV; Demissie K
    Cancer Causes Control; 2017 Aug; 28(8):809-817. PubMed ID: 28643109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
    Du XL; Fang S; Coker AL; Sanderson M; Aragaki C; Cormier JN; Xing Y; Gor BJ; Chan W
    Cancer; 2006 Mar; 106(6):1276-85. PubMed ID: 16475208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is prostate cancer different in black men? Answers from 3 natural history models.
    Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R
    Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comorbidity on survival among men with localized prostate cancer.
    Albertsen PC; Moore DF; Shih W; Lin Y; Li H; Lu-Yao GL
    J Clin Oncol; 2011 Apr; 29(10):1335-41. PubMed ID: 21357791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database.
    Tal R; Jacks LM; Elkin E; Mulhall JP
    J Sex Med; 2011 Jun; 8(6):1797-804. PubMed ID: 21426495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities and the risk of late-stage prostate cancer.
    Fleming ST; McDavid K; Pearce K; Pavlov D
    ScientificWorldJournal; 2006 Jul; 6():2460-70. PubMed ID: 17619718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.